MA30592B1 - Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques - Google Patents
Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiquesInfo
- Publication number
- MA30592B1 MA30592B1 MA31575A MA31575A MA30592B1 MA 30592 B1 MA30592 B1 MA 30592B1 MA 31575 A MA31575 A MA 31575A MA 31575 A MA31575 A MA 31575A MA 30592 B1 MA30592 B1 MA 30592B1
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- therapeutic uses
- isobutyl
- group
- eucalyptus extract
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Psychology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
Abstract
La présente invention concerne l'utilisation d'un extrait d'Eucalyptus pour la préparation d'un médicament ou d'un complément alimentaire destiné au traitement et/ou à la prévention des affections ou pathologies découlant d'un désordre de la recapture de neuromédiateurs. La présente invention concerne également un nouvel extrait enrichi d'Eucalyptus caractérisé en ce qu'il contient au moins 1 composé de formule (I) ou l'une quelconque de ses formes diastéréoisomères : dans laquelle R1 forme avec le carbone auquel il est rattaché un groupement C=CH2, un groupement , ou et R2 représente un groupement isobutyle, (alpha)-isobutyle ou (beta)-isobutyle ; ainsi que son procédé de préparation.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0607201A FR2904557B1 (fr) | 2006-08-01 | 2006-08-01 | Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques |
Publications (1)
Publication Number | Publication Date |
---|---|
MA30592B1 true MA30592B1 (fr) | 2009-07-01 |
Family
ID=37708427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA31575A MA30592B1 (fr) | 2006-08-01 | 2009-01-20 | Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques |
Country Status (20)
Country | Link |
---|---|
US (1) | US20090324754A1 (fr) |
EP (1) | EP2049133A2 (fr) |
JP (1) | JP2010500974A (fr) |
KR (1) | KR20090034401A (fr) |
CN (1) | CN101511378A (fr) |
AR (1) | AR062165A1 (fr) |
AU (1) | AU2007283529A1 (fr) |
BR (1) | BRPI0714863A2 (fr) |
CA (1) | CA2659162A1 (fr) |
FR (1) | FR2904557B1 (fr) |
IL (1) | IL196788A0 (fr) |
MA (1) | MA30592B1 (fr) |
MX (1) | MX2009000673A (fr) |
NO (1) | NO20090951L (fr) |
NZ (1) | NZ574429A (fr) |
RU (1) | RU2445112C2 (fr) |
TN (1) | TN2009000018A1 (fr) |
TW (1) | TW200820961A (fr) |
UA (1) | UA99598C2 (fr) |
WO (1) | WO2008017752A2 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2926547B1 (fr) * | 2008-01-18 | 2010-04-23 | Pf Medicament | 5-°1-(decahydro-7-hydroxy-1,1,3a,7-tetramethyl-1h- cyclopropa°a!naphtalen-4-yl)-3-methylbutyl!-2,4,6-trihydroxy -1,3-benzenedicarboxaldehyde en tant que medicaments. |
JP5602346B2 (ja) * | 2008-06-17 | 2014-10-08 | 株式会社ロッテ | ユーカリ抽出物の調製方法 |
GB2465228A (en) * | 2008-11-15 | 2010-05-19 | Athena Health Patents Inc | Analogues of phloroglucinols from eucalyptus plant varieties and related compounds and their use in treating neurodegenerative disorders |
CN102085169B (zh) * | 2011-01-30 | 2012-08-29 | 广州中涵生物科技有限公司 | 一种使黑头溶解同步收细毛孔的制剂 |
PT106278B (pt) * | 2012-04-26 | 2018-01-03 | Raiz Inst De Investigação Da Floresta E Papel | Método para a obtenção de um extrato rico em ácidos triterpénicos a partir da casca de eucalipto |
KR102115037B1 (ko) * | 2013-12-04 | 2020-05-25 | 코웨이 주식회사 | 상고머리 야테 추출물을 유효성분으로 함유하는 피부 미백용 화장료 조성물 |
JP2017501158A (ja) * | 2013-12-18 | 2017-01-12 | ティラビスコ アーベー | 嗜好性食品に対する衝動を減らすためのチラコイドの使用 |
WO2018000094A1 (fr) | 2016-06-29 | 2018-01-04 | CannScience Innovations Inc. | Résines de cannabis décarboxylées, leurs utilisations et leurs procédés de fabrication |
CN109172554A (zh) * | 2018-09-06 | 2019-01-11 | 淮安安莱生物科技有限公司 | 大果桉醛c在制备治疗人肝癌的药物方面的应用 |
KR102212193B1 (ko) | 2019-07-15 | 2021-02-03 | 박경호 | 인동등 및 유칼립투스 추출물을 유효성분으로 포함하는 인지기능장애 예방 또는 치료용 조성물 |
JP7506371B2 (ja) | 2020-01-20 | 2024-06-26 | 国立大学法人浜松医科大学 | ドーパミン減少抑制剤 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2329297A1 (fr) * | 1975-10-29 | 1977-05-27 | Rougier Yves | Inhalateur buccal |
JP3365782B2 (ja) * | 1990-11-22 | 2003-01-14 | 株式会社ロッテ | 新規マクロカルパール類及びその製造法 |
DE4447336C2 (de) * | 1994-12-31 | 1996-12-19 | Goebel Hartmut J Dr Med Habil | Verwendung eines Gemisches aus Cineol und Menthol |
JPH08198765A (ja) * | 1995-01-31 | 1996-08-06 | Hayami Kinugawa | 鎮痛用医薬組成物 |
JPH11137232A (ja) * | 1997-08-02 | 1999-05-25 | Ever Bright Ind Corp | ハーブ製品 |
US20010036488A1 (en) * | 2000-01-18 | 2001-11-01 | Syuichi Hayashi | Anti-obestic composition |
JP4809980B2 (ja) * | 2000-01-18 | 2011-11-09 | 長岡香料株式会社 | 抗動脈硬化症剤 |
EP1455778A4 (fr) * | 2001-12-19 | 2007-09-12 | The Quigley Corp | Procedes de traitement de malaises neurovasculaires peripheriques |
JP4979181B2 (ja) * | 2003-01-31 | 2012-07-18 | 株式会社ヤクルト本社 | グリケーション阻害剤及びその利用 |
JP2005272431A (ja) * | 2004-03-24 | 2005-10-06 | Yukio Kitagawa | アロマセラピー品 |
-
2006
- 2006-08-01 FR FR0607201A patent/FR2904557B1/fr not_active Expired - Fee Related
-
2007
- 2007-07-27 EP EP07823364A patent/EP2049133A2/fr not_active Withdrawn
- 2007-07-27 WO PCT/FR2007/001309 patent/WO2008017752A2/fr active Application Filing
- 2007-07-27 KR KR1020097004185A patent/KR20090034401A/ko not_active Application Discontinuation
- 2007-07-27 US US12/309,754 patent/US20090324754A1/en not_active Abandoned
- 2007-07-27 AU AU2007283529A patent/AU2007283529A1/en not_active Abandoned
- 2007-07-27 JP JP2009522297A patent/JP2010500974A/ja active Pending
- 2007-07-27 UA UAA200901761A patent/UA99598C2/ru unknown
- 2007-07-27 MX MX2009000673A patent/MX2009000673A/es not_active Application Discontinuation
- 2007-07-27 CN CNA2007800334763A patent/CN101511378A/zh active Pending
- 2007-07-27 NZ NZ574429A patent/NZ574429A/en not_active IP Right Cessation
- 2007-07-27 RU RU2009107166/15A patent/RU2445112C2/ru not_active IP Right Cessation
- 2007-07-27 BR BRPI0714863-1A patent/BRPI0714863A2/pt not_active IP Right Cessation
- 2007-07-27 CA CA002659162A patent/CA2659162A1/fr not_active Abandoned
- 2007-07-31 TW TW096127881A patent/TW200820961A/zh unknown
- 2007-08-01 AR ARP070103382A patent/AR062165A1/es not_active Application Discontinuation
-
2009
- 2009-01-19 TN TN2009000018A patent/TN2009000018A1/fr unknown
- 2009-01-20 MA MA31575A patent/MA30592B1/fr unknown
- 2009-01-29 IL IL196788A patent/IL196788A0/en unknown
- 2009-03-02 NO NO20090951A patent/NO20090951L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TN2009000018A1 (fr) | 2010-08-19 |
NO20090951L (no) | 2009-04-24 |
IL196788A0 (en) | 2009-11-18 |
NZ574429A (en) | 2012-01-12 |
AR062165A1 (es) | 2008-10-22 |
EP2049133A2 (fr) | 2009-04-22 |
MX2009000673A (es) | 2009-02-04 |
CN101511378A (zh) | 2009-08-19 |
AU2007283529A1 (en) | 2008-02-14 |
FR2904557A1 (fr) | 2008-02-08 |
RU2445112C2 (ru) | 2012-03-20 |
CA2659162A1 (fr) | 2008-02-14 |
KR20090034401A (ko) | 2009-04-07 |
RU2009107166A (ru) | 2010-09-10 |
FR2904557B1 (fr) | 2010-04-30 |
BRPI0714863A2 (pt) | 2013-05-21 |
JP2010500974A (ja) | 2010-01-14 |
WO2008017752A3 (fr) | 2008-04-10 |
TW200820961A (en) | 2008-05-16 |
US20090324754A1 (en) | 2009-12-31 |
UA99598C2 (ru) | 2012-09-10 |
WO2008017752A2 (fr) | 2008-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA30592B1 (fr) | Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques | |
MA38661A1 (fr) | Composés hétéro-aromatiques et leur utilisation en tant que ligands d1 de la dopamine | |
MA30999B1 (fr) | Composés. | |
TN2009000138A1 (fr) | Biaryl-ether-urees | |
MA29772B1 (fr) | Benzimidazoles substitues et procedes de preparation | |
MA34361B1 (fr) | Dérivés de tétrahydro-pyrido-pyrimidine | |
MA33832B1 (fr) | Isoquinolinones et quinazolinones substituées | |
BRPI0307355B8 (pt) | composto de 2,4-pirimidinodiamina, e, composição farmacêutica compreendendo o mesmo | |
MA30402B1 (fr) | Acides carboxyliques substitues par des phenylamino-benzoxazoles, leur procede de production et leur utilisation comme medicaments | |
MA31373B1 (fr) | Composes amino-heterocycliques | |
MA51669B1 (fr) | Modulateurs de tmem16a | |
MA32120B1 (fr) | Nouveaux composes chimiques | |
MA29170B1 (fr) | Derives puriniques agissant comme des agonistes du recepteur a2a | |
HUP0204023A2 (hu) | Pirrolidinacetamidszármazék alkalmazása önmagában vagy kombinációban központi idegrendszeri zavarok kezelésére és ezeket tartalmazó gyógyszerkészítmények | |
MA29411B1 (fr) | 1h-quinazoline -2,4-diones et leur utilisation en tant que ligands du recepteur ampa | |
MA30089B1 (fr) | (arylsulfonyl)-pyrasolopiperidines | |
MA33467B1 (fr) | Promédicaments comprenant un conjugué insuline-lieur | |
MA27097A1 (fr) | Aza-arylpiperazines | |
HRP20080175T3 (en) | Substituted 2-aminotetralines for the preventive treatment of parkinson's disease | |
TN2010000230A1 (fr) | Agonistes nouveaux des recepteurs de glucocorticoides | |
MA34308B1 (fr) | Triazolopyridines substituées | |
MA50013B1 (fr) | Analogues de benzoazépine utilisés en tant qu'agents inhibiteurs de la tyrosine kinase de bruton | |
MA30539B1 (fr) | Derives de piperazinyle utiles dans le traitement de maladies induites par le recepteur gpr38. | |
MA33242B1 (fr) | Composes pour le traitement de troubles metaboliques | |
MA31198B1 (fr) | Nouvelle forme dosifiee |